ADC Therapeutics SA — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-27.8% -$12M
$-56M
Free Cash Flow↑+100.0% +$90K
$0
Investing Cash Flow
$659K
Financing Cash Flow
$57M
Capex↓-100.0% -$90K
$0
Stock-Based Comp↓-58.4% -$943K
$673K
D&A↓-100.0% -$341K
$0
SBC Allocated Expense↓-58.4% -$943K
$673K